Loading...
InVivo Therapeutics Holdings Corporation
NVIV•NASDAQ
HealthcareBiotechnology
$0.32
$-0.17(-34.28%)
InVivo Therapeutics Holdings Corporation (NVIV) Company Profile & Overview
Explore InVivo Therapeutics Holdings Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
InVivo Therapeutics Holdings Corporation (NVIV) Company Profile & Overview
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
CEODr. Richard M. Toselli M.D.
Contact Information
Company Facts
6 Employees
IPO DateNov 15, 2010
CountryUS